BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9792674)

  • 1. Lysine 58 and histidine 66 at the C-terminal alpha-helix of monocyte chemoattractant protein-1 are essential for glycosaminoglycan binding.
    Chakravarty L; Rogers L; Quach T; Breckenridge S; Kolattukudy PE
    J Biol Chem; 1998 Nov; 273(45):29641-7. PubMed ID: 9792674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimerization of monocyte chemoattractant protein-1 is not required for glycosaminoglycan-dependent transendothelial chemotaxis.
    Ali S; Palmer AC; Fritchley SJ; Maley Y; Kirby JA
    Biochem J; 2001 Sep; 358(Pt 3):737-45. PubMed ID: 11535134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple glycosaminoglycan-binding epitopes of monocyte chemoattractant protein-3/CCL7 enable it to function as a non-oligomerizing chemokine.
    Salanga CL; Dyer DP; Kiselar JG; Gupta S; Chance MR; Handel TM
    J Biol Chem; 2014 May; 289(21):14896-912. PubMed ID: 24727473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure/activity analysis of human monocyte chemoattractant protein-1 (MCP-1) by mutagenesis. Identification of a mutated protein that inhibits MCP-1-mediated monocyte chemotaxis.
    Zhang YJ; Rutledge BJ; Rollins BJ
    J Biol Chem; 1994 Jun; 269(22):15918-24. PubMed ID: 8195247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo.
    Lau EK; Paavola CD; Johnson Z; Gaudry JP; Geretti E; Borlat F; Kungl AJ; Proudfoot AE; Handel TM
    J Biol Chem; 2004 May; 279(21):22294-305. PubMed ID: 15033992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-directed mutagenesis of monocyte chemoattractant protein-1 identifies two regions of the polypeptide essential for biological activity.
    Beall CJ; Mahajan S; Kuhn DE; Kolattukudy PE
    Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):633-40. PubMed ID: 8573103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2.
    Hemmerich S; Paavola C; Bloom A; Bhakta S; Freedman R; Grunberger D; Krstenansky J; Lee S; McCarley D; Mulkins M; Wong B; Pease J; Mizoue L; Mirzadegan T; Polsky I; Thompson K; Handel TM; Jarnagin K
    Biochemistry; 1999 Oct; 38(40):13013-25. PubMed ID: 10529171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of MCP-1 functional domains by peptide analysis and site-directed mutagenesis.
    Steitz SA; Hasegawa K; Chiang SL; Cobb RR; Castro MA; Lobl TJ; Yamada M; Lazarides E; Cardarelli PM
    FEBS Lett; 1998 Jul; 430(3):158-64. PubMed ID: 9688530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-directed mutagenesis of CCR2 identified amino acid residues in transmembrane helices 1, 2, and 7 important for MCP-1 binding and biological functions.
    Gavrilin MA; Gulina IV; Kawano T; Dragan S; Chakravarti L; Kolattukudy PE
    Biochem Biophys Res Commun; 2005 Feb; 327(2):533-40. PubMed ID: 15629146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV.
    Van Coillie E; Proost P; Van Aelst I; Struyf S; Polfliet M; De Meester I; Harvey DJ; Van Damme J; Opdenakker G
    Biochemistry; 1998 Sep; 37(36):12672-80. PubMed ID: 9730840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6-76) as a natural chemokine inhibitor.
    Proost P; Struyf S; Couvreur M; Lenaerts JP; Conings R; Menten P; Verhaert P; Wuyts A; Van Damme J
    J Immunol; 1998 Apr; 160(8):4034-41. PubMed ID: 9558113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of amino-acid substitutions on Alzheimer's amyloid-beta peptide-glycosaminoglycan interactions.
    McLaurin J; Fraser PE
    Eur J Biochem; 2000 Nov; 267(21):6353-61. PubMed ID: 11029577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential binding of chemokines to glycosaminoglycan subpopulations.
    Witt DP; Lander AD
    Curr Biol; 1994 May; 4(5):394-400. PubMed ID: 7922353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses.
    Kuschert GS; Coulin F; Power CA; Proudfoot AE; Hubbard RE; Hoogewerf AJ; Wells TN
    Biochemistry; 1999 Sep; 38(39):12959-68. PubMed ID: 10504268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of surface residues of the monocyte chemotactic protein 1 that affect signaling through the receptor CCR2.
    Jarnagin K; Grunberger D; Mulkins M; Wong B; Hemmerich S; Paavola C; Bloom A; Bhakta S; Diehl F; Freedman R; McCarley D; Polsky I; Ping-Tsou A; Kosaka A; Handel TM
    Biochemistry; 1999 Dec; 38(49):16167-77. PubMed ID: 10587439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing a mutant CCL2-HSA chimera with high glycosaminoglycan-binding affinity and selectivity.
    Gerlza T; Winkler S; Atlic A; Zankl C; Konya V; Kitic N; Strutzmann E; Knebl K; Adage T; Heinemann A; Weis R; Kungl AJ
    Protein Eng Des Sel; 2015 Aug; 28(8):231-40. PubMed ID: 25969511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and function of the glycosaminoglycan binding site of chemokine macrophage-inflammatory protein-1 beta.
    Koopmann W; Ediriwickrema C; Krangel MS
    J Immunol; 1999 Aug; 163(4):2120-7. PubMed ID: 10438952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosaminoglycan binding properties of the myxoma virus CC-chemokine inhibitor, M-T1.
    Seet BT; Barrett J; Robichaud J; Shilton B; Singh R; McFadden G
    J Biol Chem; 2001 Aug; 276(32):30504-13. PubMed ID: 11369757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A non-glycosaminoglycan-binding variant of CC chemokine ligand 7 (monocyte chemoattractant protein-3) antagonizes chemokine-mediated inflammation.
    Ali S; Robertson H; Wain JH; Isaacs JD; Malik G; Kirby JA
    J Immunol; 2005 Jul; 175(2):1257-66. PubMed ID: 16002730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues.
    Gong JH; Clark-Lewis I
    J Exp Med; 1995 Feb; 181(2):631-40. PubMed ID: 7836918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.